Insight

State of the Science of Single-Dose Prophylactic HPV Vaccination – NCI Division of Cancer Prevention

verywellhealth.com

Nov 17, 2024, 16:02

State of the Science of Single-Dose Prophylactic HPV Vaccination – NCI Division of Cancer Prevention

NCI Division of Cancer Prevention shared a post on LinkedIn:

“Just published in JNCI – State of the Science of Single-Dose Prophylactic HPV Vaccination.

This monograph, featuring National Cancer Institute (NCI)-supported research and several NCI co-authors, adds to and reinforces earlier findings that across multiple geographies, single-dose HPV vaccination provides strong protection against cancer-causing HPV infection, while also providing opportunities to reduce ongoing vaccination program costs and expand coverage.

Read the summary here.
And the full publication.

NCI authors: Aimee Kreimer, Danping Liu, Douglas Lowy, John Schiller, Mitchell Gail, Mónica S. Sierra, Mark Schiffman, Silvia de Sanjose.”

Prophylactic

Aimee Kreimer cancer Danping Liu Douglas Lowy JNCI John Schiller Mark Schiffman Mitchell Gail Mónica S. Sierra NCI NCI Division of Cancer Prevention OncoDaily Oncology Silvia de Sanjose

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer

Black History Month 2025: Honoring Contributions to Oncology